SCHEMBL6850383

SCHEMBL6850383

C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)C(=O)OCC4(O[Si](CC)(CC)CC)CCCCC4)CC[C@@H]23)C[C@@H](O[Si](C)(C)C(C)(C)C)C[C@H]1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ VDR P11473 15/20 0.42
▸ MAPT P10636 2/20 0.42
▸ NR1I2 O75469 1/20 0.42
▸ ABCB11 O95342 1/20 0.42
▸ GC P02774 1/20 0.42
▸ PGR P06401 1/20 0.42
▸ ADORA3 P0DMS8 1/20 0.42
▸ RXRA P19793 1/20 0.42
▸ CHRM3 P20309 1/20 0.42
▸ CNR1 P21554 1/20 0.42
▸ SLC6A2 P23975 1/20 0.42
▸ HTR2C P28335 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ AGTR1 P30556 1/20 0.42
▸ SLC6A4 P31645 1/20 0.42
▸ ADRA1A P35348 1/20 0.42
▸ PTGS2 P35354 1/20 0.42
▸ OPRD1 P41143 1/20 0.42
▸ OPRK1 P41145 1/20 0.42
▸ SLC6A3 Q01959 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6850576 0.89 VDR (0.43) VDR
SCHEMBL6849080 0.89 VDR (0.43) VDR
SCHEMBL6849075 0.88 VDR (0.44) VDR
SCHEMBL9364902 0.86 VDR (0.47) VDRMAPTNR1I2ABCB11GC
SCHEMBL6850743 0.82 VDR (0.42) VDR
SCHEMBL6852073 0.82 VDR (0.42) VDR
SCHEMBL6851130 0.81 VDR (0.43) VDR
SCHEMBL13867357 0.81 VDR (0.51) VDRMAPTNR1I2ABCB11GC
SCHEMBL25313440 0.81 VDR (0.54) VDRMAPTNR1I2ABCB11GC
SCHEMBL25313435 0.81 VDR (0.54) VDRMAPTNR1I2ABCB11GC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0805682-B1 DERMATOLOGICAL USE OF VITAMIN D DERIVATIVES BASILEA PHARMACEUTICA AG (CH) 2004-08-11 — — EP disclosed
US-5827883-A TOPICAL DRUG DELIVERY; SIDE EFFECT REDUCTION HOFFMANN-LA ROCHE INC. (US) 1998-10-27 — — US disclosed
Send feedback